FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Increased expression of both FGF proteins and their receptors observed in many cancers is often associated with the development of chemoresistance, limiting the effectiveness of currently used anti-cancer therapies. Malfunctioning of the FGF/FGFR axis in cancer cells generates a number of molecular...
Guardado en:
Autores principales: | Jakub Szymczyk, Katarzyna Dominika Sluzalska, Izabela Materla, Lukasz Opalinski, Jacek Otlewski, Malgorzata Zakrzewska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e265c83e558d4be7976e7d68c9528fa3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biological Significance and Targeting of the FGFR Axis in Cancer
por: Athina-Myrto Chioni, et al.
Publicado: (2021) -
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
por: Yunju Nam, et al.
Publicado: (2022) -
Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
por: Karolina Jendryczko, et al.
Publicado: (2021) -
The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration
por: Mariya Farooq, et al.
Publicado: (2021) -
Heat Shock Proteins HSPA1 and HSP90AA1 Are Upregulated in Colorectal Polyps and Can Be Targeted in Cancer Cells by Anti-Inflammatory Oxicams with Arylpiperazine Pharmacophore and Benzoyl Moiety Substitutions at Thiazine Ring
por: Izabela Szczuka, et al.
Publicado: (2021)